|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.24 EGP | +1.69% |
|
+2.46% | +15.07% |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
| 03-12 | GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.69% | +2.46% | -0.46% | +17.18% | +15.07% | +88.28% | +133.99% | +105.04% | +751.63% | 123M | |
| -1.60% | +2.02% | +5.80% | +27.54% | +13.13% | +56.34% | +168.94% | +412.75% | +1,426.27% | 1,084B | |
| -1.44% | +3.71% | +13.46% | +9.16% | +27.28% | +69.07% | +65.40% | +55.78% | +114.41% | 634B | |
| -0.75% | +0.67% | +13.30% | +19.45% | +10.61% | +33.18% | +86.52% | +117.22% | +293.92% | 447B | |
| -0.36% | -2.11% | +4.86% | +5.56% | +1.86% | +28.58% | +26.03% | -5.32% | +30.64% | 330B | |
| -8.51% | -10.32% | -4.36% | -14.65% | -5.45% | +25.83% | +28.07% | +50.76% | +186.17% | 295B | |
| -0.62% | -2.06% | +5.91% | +2.62% | +14.40% | +28.53% | +46.16% | +47.61% | +54.22% | 285B | |
| -1.08% | -3.55% | +18.81% | +34.48% | -1.55% | -27.73% | -39.69% | +17.59% | +71.83% | 218B | |
| -0.03% | +1.84% | +6.44% | +5.20% | +12.43% | +23.90% | +68.30% | +50.64% | +128.42% | 199B | |
| -0.40% | +7.82% | +6.03% | -4.04% | +10.66% | +22.29% | +82.50% | +100.65% | +56.93% | 169B | |
| -0.08% | +0.71% | -6.13% | -12.45% | -3.41% | -6.13% | -32.31% | -38.73% | -33.42% | 137B | |
| -4.56% | +0.08% | +12.52% | +12.28% | +9.94% | +6.88% | +47.39% | +152.06% | +460.29% | 127B | |
| -0.74% | +1.95% | +3.55% | -2.80% | +6.67% | +22.32% | -8.16% | -13.72% | -23.57% | 118B | |
| -1.12% | -2.17% | +2.99% | -9.53% | +7.45% | +37.58% | +48.91% | +9.28% | -5.66% | 105B | |
| +0.93% | +1.06% | -1.29% | -6.02% | -8.06% | -8.73% | -19.36% | -12.81% | +1.67% | 103B | |
| +0.19% | -0.82% | -0.23% | -16.14% | -10.72% | +8.13% | +92.24% | +78.44% | +480.97% | 74.31B | |
| +0.87% | -6.11% | +41.17% | +23.86% | +35.37% | +83.32% | +1.14% | -1.44% | -45.98% | 55.6B | |
| -2.44% | +0.43% | +17.57% | -5.99% | -9.33% | +1.14% | +11.61% | -11.99% | +258.96% | 52.46B | |
| -0.97% | +2.35% | +8.50% | -7.27% | +11.64% | +21.85% | +22.46% | +48.13% | +23.16% | 52.94B | |
| -1.27% | -0.08% | +7.33% | -1.18% | -3.92% | -1.93% | +15.64% | - | - | 42.83B | |
| Average | -0.93% | +2.32% | +7.79% | +3.86% | +6.70% | +25.64% | +42.29% | +61.16% | +222.68% | 226.39B | |
| Weighted average by Cap. | -0.86% | +2.36% | +7.61% | +10.55% | +10.15% | +35.21% | +71.84% | +136.57% | +441.47% |
- Stock Market
- Stocks
- BIOC Stock
- Sector GlaxoSmithKline S.A.E
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
